Draper’s Millions: The Philanthropic Wellspring of Modern Race Science
By Angela Saini,
Undark
| 12. 16. 2022
In 1961, a new journal of ethnology and anthropology appeared on academic bookshelves. Nearly every page betrayed an obsession with racial differences.
“The few worthwhile contributions cannot justify the publication of the rest of the journal,” wrote the English anthropologist G. Ainsworth Harrison, spotting error after error. “None of the authors rigorously and objectively appraises the limitations of the tests he uses.” One article made the bizarre claim that Egypt — a country described as being made up of racial “hybrids” — was more “disease-ridden” as a result. “What is particularly insidious in a supposedly scientific journal is the use of words with overtones of moral judgment,” Harrison concluded.
What he didn’t know was that this was entirely by design. The journal had been founded by a tight web of far-right thinkers intent on blocking racial integration in the United States, ending immigration from everywhere but Western Europe, and promoting eugenic policies that would encourage only those they believed were the fittest to survive and reproduce. They were relying on the naivete of fellow researchers, using academia as cover so...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...